The tenascin-C knockout revisited

Journal of Cell Science

Volumn 112, Issue 22, 1999, Pages 3847-3853

  Mackie, Eleanor J ^a   Tucker, Richard P ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Extracellular matrix; Homologous recombination; Phenotype

Indexed keywords

FIBRONECTIN; GLYCOPROTEIN; SNAKE VENOM; TENASCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BEHAVIOR DISORDER; BONE MARROW; BRAIN LEVEL; CHEMICAL INJURY; CORNEA INJURY; DERMATITIS; GLOMERULONEPHRITIS; HEMATOPOIESIS; KNOCKOUT MOUSE; MOUSE; NEUROMUSCULAR SYNAPSE; NONHUMAN; NOTE; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; SUTURE; WOUND HEALING;

AMINO ACID SEQUENCE; ANIMALS; BEHAVIOR, ANIMAL; DERMATITIS; GLOMERULONEPHRITIS; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; NEUROMUSCULAR JUNCTION; SEQUENCE HOMOLOGY, AMINO ACID; TENASCIN; WOUND HEALING;

ANIMALIA; SERPENTES;

EID: 0033491886     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (61)

1. Assad, L., Schwartz, M. M., Virtanen, I. and Gould, V. E. (1993). Immunolocalization of tenascin and cellular fibronectins in diverse glomerulopathies. Virchows Arch. B Cell Pathol. Include. Mol. Pathol. 63, 307-316.
2. Aufderheide, E., Chiquet-Ehrismann, R. and Ekblom, P. (1987). Epithelialmesenchymal interactions in the developing kidney lead to expression of tenascin in the mesenchyme. J. Cell Biol. 105, 599-608.
3. Bourdon, M. A., Wikstrand, C. J., Furthmayer, H., Matthews, T. J. and Bigner, D. D. (1983). Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res. 43, 2796-2805.
4. Chiquet-Ehrismann, R., Mackie, E. J., Adams Pearson, C. and Sakakura, T. (1986). Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47, 131-139.
5. Chiquet-Ehrismann, R., Kalla, P., Pearson, C. A., Beck, K. and Chiquet, M. (1988). Tenascin interferes with fibronectin action. Cell 53, 383-390.
6. Chiquet-Ehrismann, R., Hagios, C., and Matsumoto, K. (1994a). The tenascin gene family. Perspect. Dev. Neurobiol. 2, 3-7.
7. Chiquet-Ehrismann, R., Tannheimer, M., Koch, M., Brunner, A., Spring, J., Martin, D., Baumgartner, S. and Chiquet, M. (1994b). Tenascin-C expression by fibroblasts is elevated in stressed collagen gels. J. Cell Biol. 127, 2093-2101.
8. Chiquet-Ehrismann, R. (1995). Tenascins, a growing family of extracellular matrix proteins. Experientia 51, 853-862.
9. Chuong, C. M. and Chen, H. M. (1991). Enhanced expression of neural cell adhesion molecules and tenascin (cytotactin) during wound healing. Am. J. Pathol. 138, 427-440.
10. Cifuentes-Diaz, C., Velasco, E., Meunier, F. A., Goudou, D., Belkadi, L., Faille, L., Murawsky, M., Angaut-Petit, D., Molgo, J., Schachner, M., Saga, Y., Aizawa, S. and Rieger, F. (1998). The peripheral nerve and the neuromuscular junction are affected in the tenascin-C-deficient mouse. Cell Mol. Biol. (Noisy-le-grand) 44, 357-379.
11. Crossin, K. L., Prieto, A. L., Hoffman, S., Jones, F. S. and Friedlander, D. R. (1990). Expression of adhesion molecules and the establishment of boundaries during embryonic and neural development. Exp. Neurol. 109, 6-18.
12. Daniloff, J. K., Crossin, K. L., Pincon-Raymond, M., Murawsky, M., Rieger, F. and Edelman, G. M. (1989). Expression of cytotactin in the normal and regenerating neuromuscular system. J. Cell Biol. 108, 625-635.
13. Erickson, H. P. (1993a). Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. Curr. Opin. Cell Biol. 5, 869-876.
14. Erickson, H. P. (1993b). Gene knockouts of c-src, transforming growth factor beta 1, and tenascin suggest superfluous, nonfunctional expression of proteins. J. Cell Biol. 120, 1079-1081.
15. Erickson, H. P. (1994). Evolution of the tenascin family - implications for function of the C-terminal fibrinogen-like domain. Perspect. Dev. Neurobiol. 2, 9-19.
16. Faissner, A., Scholze, A., and Gotz, B. (1994). Tenascin glycoproteins in developing neural tissues: only decoration? Perspect. Dev. Neurobiol. 2, 53-66.
17. Faissner, A. (1997). The tenascin gene family in axon growth and guidance. Cell Tissue Res. 290, 331-341.
18. Forsberg, E., Hirsch, E., Frohlich, L., Meyer, M., Ekblom, P., Aszodi, A., Werner, S. and Fassler, R. (1996). Skin wounds and severed nerves heal normally in mice lacking tenascin-C. Proc. Nat. Acad. Sci. USA 93, 6594-6599.
19. Fukamauchi, F., Mataga, N., Wang, Y. J., Sato, S., Youshiki, A. and Kusakabe, M. (1996). Abnormal behavior and neurotransmissions of tenascin gene knockout mouse. Biochem. Biophys. Res. Commun. 221, 151-156.
20. Fukamauchi, F. and Kusakabe, M. (1997). Preprotachykinin A and cholecystokinin mRNAs in tenascin-gene knockout mouse brain. Neuropeptides. 31, 199-201.
21. Fukamauchi, F., Mataga, N., Wang, Y. J., Sato, S., Yoshiki, A. and Kusakabe, M. (1997a). Tyrosine hydroxylase activity and its mRNA level in dopaminergic neurons of tenascin gene knockout mouse. Biochem. Biophys. Res. Commun. 231, 356-359.
22. Fukamauchi, F., Wang, Y. J., Mataga, N. and Kusakabe, M. (1997b). Paradoxical behavioral response to apomorphine in tenascin-gene knockout mouse. Eur. J. Pharmacol. 338, 7-10.
23. Fukamauchi, F., Wang, Y. J., Mataga, N. and Kusakabe, M. (1997c). Effects of cholecystokinin-B receptor antagonist on dopamine system in tenascin mutant mice. Neuroreport 8, 3919-3922.
24. Fukamauchi, F., Aihara, O. and Kusakabe, M. (1998a). Reduced mRNA expression of neuropeptide Y in the limbic system of tenascin gene disrupted mouse brain. Neuropeptides 32, 265-268.
25. Fukamauchi, F., Aihara, O. and Kusakabe, M. (1998b). The effects of central administration of neuropeptide Y on behavior of tenascin-gene knockout mice. Neuropeptides 32, 461-464.
26. Gates, M. A., Thomas, L. B., Howard, E. M., Laywell, E. D., Sajin, B., Faissner, A., Gotz, B., Silver, J., and Steindler, D. A. (1995). Cell and molecular analysis of the developing and adult mouse subventricular zone of the cerebral hemispheres. J. Comp. Neurol. 361, 249-266.
27. Halfter, W., Chiquet-Ehrismann, R., Tucker, R. P. (1989). The effect of tenascin and embryonic basal lamina on the behavior and morphology of neural crest cells in vitro. Dev. Biol. 132, 14-25.
28. Klein, G., Beck, S. and Muller, C. A. (1993). Tenascin is a cytoadhesive extracellular matrix component of the human hematopoietic microenvironment. J. Cell Biol. 123, 1027-1035.
29. Koyama, Y., Norose, K., Kusubata, M., Irie, S. and Kusakabe, M. (1996). Differential expression of tenascin in the skin during hapten-induced dermatitis. Histochem. Cell Biol. 106, 263-273.
30. Koyama, Y., Kusubata, M., Yoshiki, A., Hiraiwa, N., Ohashi, T., Irie, S. and Kusakabe, M. (1998). Effect of tenascin-C deficiency on chemically induced dermatitis in the mouse. J. Invest. Dermatol. 111, 930-935.
31. Langenfeld-Oster, B., Faissner, A., Irintchev, A. and Wernig, A. (1994). Polyclonal antibodies against NCAM and tenascin delay endplate reinnervation. J. Neurocytol. 23, 591-604.
32. Laywell, E. D., Dorries, U., Bartsch, U., Faissner, A., Schachner, M. and Steindler, D. A. (1992). Enhanced expression of the developmentally regulated extracellular matrix molecule tenascin following adult brain injury. Proc. Nat. Acad. Sci. U S A 89, 2634-2638.
33. Lotz, M. M., Burdsal, C. A., Erickson, H. P. and McClay, D. R. (1989). Cell adhesion to fibronectin and tenascin: quantitative measurements of initial binding and subsequent strengthening response. J. Cell Biol. 109, 1795-1805.
34. Mackie, E. J., Thesleff, I. and Chiquet-Ehrismann, R. (1987). Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro. J. Cell Biol. 105, 2569-2579.
35. Mackie, E. J., Halfter, W. and Liverani, D. (1988). Induction of tenascin in healing wounds. J. Cell Biol. 107, 2757-2767.
36. Mackie, E. J., and Tucker, R. P. (1992). Tenascin in bone morphogenesis: expression by osteoblasts and cell type-specific expression of splice variants. J. Cell Sci. 103, 765-771.
37. Mackie, E. J. (1997). Molecules in focus: tenascin-C. Int. J. Biochem. Cell Biol. 29, 1133-1137.
38. Martini, R., Schachner, M. and Faissner, A. (1990). Enhanced expression of the extracellular matrix molecule J1/tenascin in the regenerating adult mouse sciatic nerve. J. Neurocytol. 19, 601-616.
39. Matsuda, A., Yoshiki, A., Tagawa, Y., Matsuda, H. and Kusakabe, M. (1999). Corneal wound healing in tenascin knockout mouse. Invest. Ophthalmol. Vis. Sci. 40, 1071-1080.
40. Mege, R. M., Nicolet, M., Pincon-Raymond, M., Murawsky, M. and Rieger, F. (1992). Cytotactin is involved in synaptogenesis during regeneration of the frog neuromuscular system. Dev. Biol. 149, 381-394.
41. Miragall, F., Kadmo, G., Faissner, A., Antonicek, H., and Schachner, M. (1990). Retention of J1/tenascin and the polysialylated form of the neural cell adhesion molecule (N-CAM) in the adult olfactory bulb. J. Neurocytol. 19, 899-914.
42. Mitrovic, N. and Schachner, M. (1995). Detection of tenascin-C in the nervous system of the tenascin-C mutant mouse. J. Neurosci. Res. 42, 710-717.
43. Moscoso, L. M., Cremer, H. and Sanes, J. R. (1998). Organization and reorganization of neuromuscular junctions in mice lacking neural cell adhesion molecule, tenascin-C, or fibroblast growth factor-5. J. Neurosci. 18, 1465-1477.
44. Nakao, N., Hiraiwa, N., Yoshiki, A., Ike, F. and Kusakabe, M. (1998). Tenascin-C promotes healing of Habu-snake venom-induced glomerulonephritis: studies in knockout congenic mice and in culture. Am. J. Pathol. 152, 1237-1245.
45. Oberhauser, A. F., Marszalek, P. E., Erickson, H. P., and Fernandez, J. M. (1998). The molecular elasticity of the extracellular matrix protein tenascin. Nature 393, 181-185.
46. Ohta, M., Sakai, T., Saga, Y., Aizawa, S. and Saito, M. (1998). Suppression of hematopoietic activity in tenascin-C-deficient mice. Blood 91, 4074-4083.
47. Probstmeier, R. and Pesheva, P. (1999). Tenascin-C inhibits hetal integrin-dependent cell adhesion and neurite outgrowth on fibronectin by a disialoganglioside-mediated signaling mechanism. Glycobiology 9, 101-114.
48. Rieger, F., Daniloff, J. K., Pincon-Raymond, M., Crossin, K. L., Grumet, M. and Edelman, G. M. (1986). Neuronal cell adhesion molecules and cytotactin are colocalized at the node of Ranvier. J. Cell Biol. 103, 379-391.
49. Saga, Y., Yagi, T., Ikawa, Y., Sakakura, T. and Aizawa, S. (1992). Mice develop normally without tenascin. Genes Dev. 6, 1821-1831.
50. Sakai, T., Furukawa, Y., Chiquet-Ehrismann, R., Nakamura, M., Kitagawa, S., Ikemura, T. and Matsumoto, K. (1996). Tenascin-X expression in tumor cells and fibroblasts: glucocorticoids as negative regulators in fibroblasts. J. Cell Sci. 109, 2069-2077.
51. Sanes, J. R., Schachner, M. and Covault, J. (1986). Expression of several adhesive macromolecules (N-CAM, L1, J1, NILE, uvomorulin, laminin, fibronectin, and a heparan sulfate proteoglycan) in embryonic, adult, and denervated adult skeletal muscle. J. Cell Biol. 102, 420-431.
52. Schalkwijk, J., Steijlen, P. M., van Vlijmen-Willems, I. M., Oosterling, B., Mackie, E. J. and Verstraeten, A. A. (1991). Tenascin expression in human dermis is related to epidermal proliferation. Am. J. Pathol. 139, 1143-1150.
53. Seiffert, M., Beck, S. C., Schermutzki, F., Muller, C. A., Erickson, H. P. and Klein, G. (1998). Mitogenic and adhesive effects of tenascin-C on human hematopoietic cells are mediated hy various functional domains. Matrix Biol. 17, 47-63.
54. Settles, D. L., Kusakabe, M., Steindler, D. A., Fillmore, H. and Erickson, H. P. (1997). Tenascin-C knockout mouse has no delectable tenascin-C protein. J. Neurosci. Res. 47, 109-117.
55. Srinivasan, J., Schachner, M. and Catterall, W. A. (1998). Interaction of voltage-gated sodium channels with the extracellular matrix molecules tenascin-C and tenascin-R. Proc. Nat. Acad. Sci. USA 95, 15753-15757.
56. Steindler, D. A., Cooper, N. G., Faissner, A. and Schachner, M. (1989). Boundaries defined by adhesion molecules during development of the cerebral cortex: the J1/tenascin glycoprotein in the mouse somatosensory cortical barrel field. Dev. Biol. 131, 243-260.
57. Steindler, D. A., Settles, D., Erickson, H. P., Laywell, E. D., Yoshiki, A., Faissner, A. and Kusakabe, M. (1995). Tenascin knockout mice: barrels, boundary molecules, and glial scars. J. Neurosci. 15, 1971-1983.
58. Talts, J. F., Wirl, G., Dictor, M., Muller, W. J. and Fässler, R. (1999). Tenascin-C modulates tumor stroma and monocyte/macrophage recruitment but not tumor growth or metastasis in a mous strain with spontaneous mammary cancer. J. Cell Sci. 112, 1855-1864.
59. Tervo, K., van Setten, G. B., Beuerman, R. W., Virtanen, I., Tarkkanen, A. and Tervo, T. (1991). Expression of tenascin and cellular fibronectin in the rabbit cornea after anterior keratectomy. Immunohistochemical study of wound healing dynamics. Invest. Ophthalmol. Vis. Sci. 32, 2912-2918.
60. Tucker, R. P., Brunso-Bechtold, J. K., Jenrath, D. A., Khan, N. A., Poss, P. M., Sweatt, A. J. and Xu, Y. (1994). Cellular origins of tenascin in the developing nervous system. Perspect. Dev. Neurobiol. 2, 89-99.
61. Tucker, R. P. (ed. ) (1994). The function of tenascin: hypotheses and current knowledge. Perspect. Dev. Neurobiol. 2, 1-132.